Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the N-Methyl-D-Aspartate (Nmda)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective
Abdolreaza Naser Moghadasi
Abdolreaza Naser Moghadasi

Associate Professor of Neurology

Department Neurology

School of Medicine

Sina Hospital

Multiple Sclerosis Research Center

Tehran University of Medical Sciences

All Documents
1. Computerized Cognitive Rehabilitation in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2025)
2. Effects of Non-Pharmacological Interventions on Gait and Balance of Persons With Multiple Sclerosis: A Narrative Review, Multiple Sclerosis and Related Disorders (2024)
3. Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis: A Phase Iii, Randomized, Equivalency, Clinical Trial, Scientific Reports (2024)
4. Good Manufacturing Practices Production of Human Placental Derived Mesenchymal Stem Cells for Therapeutic Applications: Focus on Multiple Sclerosis, Molecular Biology Reports (2024)
5. Presence of Palinopsia As a Sign of Selective Cns Tractopathy: A Case Report; [Presencia De Palinopsia Como Signo De Tractopatia Selectiva Del Snc: Reporte De Un Caso], Revista Cientifica de la Sociedad Espanola de Enfermeria Neurologica (2024)
6. Acute Attack in a Patient With Multiple Sclerosis 2 Days After Covid Vaccination: A Case Report, Acta Neurologica Belgica (2023)
7. Association of Body Mass Index and Physical Activity With Fatigue, Depression, and Anxiety Among Iranian Patients With Multiple Sclerosis, Frontiers in Neurology (2023)
8. Characteristics and Management of Multiple Sclerosis Patients During the Omicron Era: Is There a Concern About the Ms Course in the Face of the New Variant of Covid-19?, Neurological Sciences (2023)
9. Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2023)
10. Effectiveness and Safety of Switching From Fingolimod and Natalizumab to Rituximab in Patients With Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
11. Effectiveness of Acupuncture for Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Acupuncture in Medicine (2023)
12. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
13. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
14. Higher Dietary Acid Load Might Be a Potent Derivative Factor for Multiple Sclerosis: The Results From a Case–Control Study, Nutrients (2023)
15. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
16. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
17. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
18. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
19. Radiological Features of Late-Onset Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2023)
20. The Association of Upper Respiratory Infections With Neuro-Radiological Course and Attack Rate of Multiple Sclerosis: Results From a Large Prospective Cohort, Multiple Sclerosis Journal - Experimental# Translational and Clinical (2023)
21. The First Ms Attack After Methanol Toxicity in a Young Man: A Case Report, Neurological Sciences (2023)
22. The Importance of Autologous Hematopoietic Stem Cell Transplantation in Severe Cases of Neuromyelitis Optica Spectrum Disorder, Journal of Clinical Neuroscience (2023)
23. Waterpipe and Cigarette Smoking and Drug and Alcohol Consumption, and the Risk of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Current Journal of Neurology (2023)
24. [18F]Fdg Brain Pet and Clinical Symptoms in Different Autoantibodies of Autoimmune Encephalitis: A Systematic Review, Neurological Sciences (2022)
25. [18F]Fdg Brain Pet and Clinical Symptoms in Different Autoantibodies of Autoimmune Encephalitis: A Systematic Review, Neurological Sciences (2022)
26. A One Year Follow of Patients With Multiple Sclerosis During Covid-19 Pandemic: A Cross-Sectional Study in Qom Province, Iran, Multiple Sclerosis and Related Disorders (2022)
27. Acupuncture for Multiple Sclerosis: A Literature Review, Multiple Sclerosis and Related Disorders (2022)
28. Acute Disseminated Encephalomyelitis (Adem) Following Sars-Cov-2 Infection: A Case Report From Iran; [Encefalomielitis Diseminada Aguda (Adem) Tras Infeccion Por Sars-Cov-2: Caso Clinico En Iran], Revista Cientifica de la Sociedad Espanola de Enfermeria Neurologica (2022)
29. Artificial Intelligence in the Diagnosis of Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2022)
30. Artificial Intelligence in the Diagnosis of Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2022)
31. Autoimmune Encephalitis Associated With Covid-19: A Systematic Review, Multiple Sclerosis and Related Disorders (2022)
32. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
33. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
34. Complementary and Alternative Therapies in Multiple Sclerosis: A Systematic Literature Classification and Analysis, Acta Neurologica Belgica (2022)
35. Covid-19 Vaccine Hesitancy in Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
36. Depression, Anxiety, and Fear of Covid-19 in Patients With Multiple Sclerosis in Pandemic Era: A Cross-Sectional Study, Neurological Sciences (2022)
37. Determining the Effect of Sun Exposure and Physical Activity on the Incidence of Primary Progressive Multiple Sclerosis, Tehran University Medical Journal (2022)
38. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
39. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
40. Gut Microbiome in Multiple Sclerosis-Related Cognitive Impairment, Multiple Sclerosis and Related Disorders (2022)
41. Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Series From Iran, Revue Neurologique (2022)
42. Mind Diet Adherence Might Be Associated With a Reduced Odds of Multiple Sclerosis: Results From a Case–Control Study, Neurology and Therapy (2022)
43. Neglected Aspect: Some Points on How to Deal With Cognitive Disorders in People With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
44. Obsessive Compulsive Disorder As a Presenting Symptom of Covid-19: A Case-Series From Iran, Caspian Journal of Internal Medicine (2022)
45. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
46. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
47. Quantitative Changes in Gait Parameters After Cycling Among Multiple Sclerosis Patients With Ataxia:A Pilot Study, Journal of Modern Rehabilitation (2022)
48. Statins and Risk of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2022)
49. Telemedicine As a Strategic Intervention for Cognitive Rehabilitation in Ms Patients During Covid-19, Acta Neurologica Belgica (2022)
50. The Role of Semantic Memory in Reducing Learning Disability in Multiple Sclerosis Patients, Clinical Schizophrenia and Related Psychoses (2022)
51. The Study of Covid-19 Infection Following Vaccination in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
52. Treatment of Multiple Sclerosis As a Single Disease Based on the Body-Pathology-Environment Model, Multiple Sclerosis and Related Disorders (2022)
53. Watch Out for Neuromyelitis Optica Spectrum Disorder Onset or Clinical Relapse After Covid-19 Vaccination: What Neurologists Need to Know?, Multiple Sclerosis and Related Disorders (2022)
54. A 31-Year-Old Female Patient With Concurrent Clinical Onset of Multiple Sclerosis and Covid-19: Possible Role of Sars-Cov-2 in the Pathogenesis of Multiple Sclerosis, Autoimmunity Reviews (2021)
55. A Focus on Allogeneic Mesenchymal Stromal Cells As a Versatile Therapeutic Tool for Treating Multiple Sclerosis, Stem Cell Research and Therapy (2021)
56. A Smartphone-Based Application for Self-Management in Multiple Sclerosis, Journal of Healthcare Engineering (2021)
57. Adverse Events Reported by Iranian Patients With Multiple Sclerosis After the First Dose of Sinopharm Bbibp-Corv, Vaccine (2021)
58. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient With Multiple Sclerosis on Dimethyl Fumarate: A Case Report, Neurological Sciences (2021)
59. Association of Covid-19 and Acute Disseminated Encephalomyelitis (Adem) in the Absence of Pulmonary Involvement, Autoimmunity Reviews (2021)
60. Attitudes Toward Vaccination in Patients With Multiple Sclerosis: A Report From Iran, Multiple Sclerosis and Related Disorders (2021)
61. Beta-Thalassemia Intermedia With Ischemic Transients Misdiagnosed As Multiple Sclerosis: A Case Report, Current Journal of Neurology (2021)
62. Biosimilars in Treatment of Multiple Sclerosis in Iran, Archives of Iranian Medicine (2021)
63. Can Pulse Steroid Therapy Increase the Risk of Infection by Covid-19 in Patients With Multiple Sclerosis?, Clinical Neurology and Neurosurgery (2021)
64. Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?, Frontiers in Emergency Medicine (2021)
65. Covid-19-Related Autoimmune Disorders of Central Nervous System (Crad-C): Is It a New Entity?, Autoimmunity Reviews (2021)
66. Demographic Features, Behavioral Measures, and Clinical Factors As Predictors of Cognitive Function in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
67. Dietary Risk Factors of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2021)
68. Economic Sanctions Against Iran As an Important Factor in Threatening the Health of Patients With Multiple Sclerosis, Current Journal of Neurology (2021)
69. Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A, Frontiers in Emergency Medicine (2021)
70. Exome Sequencing Reveals Novel Rare Variants in Iranian Familial Multiple Sclerosis: The Importance of Pold2 in the Disease Pathogenesis, Genomics (2021)
71. Explaining the Individual Challenges of Women Affected by Neuromyelitis Optica and Multiple Sclerosis: A Comparative Content Analysis Study, Clinical Neurology and Neurosurgery (2021)
72. Expression Analysis of Nf-Κb-Associated Long Noncoding Rnas in Peripheral Blood Mononuclear Cells From Relapsing-Remitting Multiple Sclerosis Patients, Journal of Neuroimmunology (2021)
73. Implementing Coronavirus Disease 2019 Scale-Up Registry Protocol in National Multiple Sclerosis Registry System of Iran, Current Journal of Neurology (2021)
74. Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed, Multiple Sclerosis and Related Disorders (2021)
75. Increased Intracranial Pressure on a Patient With Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Internal Medicine (2021)
76. Lack of Attention to the Administration of Fampridine As a Symptomatic Drug in Iranian Multiple Sclerosis Patients, Iranian Journal of Public Health (2021)
77. Medical History Risk Factors in Primary Progressive Multiple Sclerosis: A Case-Control Study, Current Journal of Neurology (2021)
78. Neuromyelitis Optica Spectrum Disorder (Nmosd) Associated With Cancer: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)
79. Optimization of Expression and Extraction of Toxocara Canis Recombinant C-Type Lectin Protein in Escherichia Coli Bl21 (De3), Journal of Veterinary Research (2021)
80. Outcomes of Laparoscopic One-Anastomosis Gastric Bypass (Oagb) in Patients With Morbid Obesity and Multiple Sclerosis, Obesity Surgery (2021)
81. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
82. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
83. Pregnancy Outcome in Patients With Neuromyelitis Optica Spectrum Disorder Treated With Rituximab: A Case-Series Study, Caspian Journal of Internal Medicine (2021)
84. Pregnancy Outcome in Patients With Neuromyelitis Optica Spectrum Disorder Treated With Rituximab: A Case-Series Study, Caspian Journal of Internal Medicine (2021)
85. Rna Sequencing of Cd4+ T Cells in Relapsing–Remitting Multiple Sclerosis Patients at Relapse: Deciphering the Involvement of Novel Genes and Pathways, Journal of Molecular Neuroscience (2021)
86. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
87. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
88. Sleep Disorders As a Possible Predisposing Attack Factor in Neuromyelitis Optica Spectrum Disorder (Nmosd): A Case-Control Study, Clinical Neurology and Neurosurgery (2021)
89. Stressful Life Events and the Risk of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2021)
90. The Association Between Dietary Total Antioxidant Capacity and Nmo-Igg Seropositivity in Patients With Neuromyelitis Optica Spectrum Disorder, Clinical Neurology and Neurosurgery (2021)
91. The First Presentation of Covid-19 Two Hours After Vaccination in a Patient With Multiple Sclerosis: Can Covid Vaccine Provoke Cytokine Storm in a Patient With Asymptomatic Covid-19?, Current Journal of Neurology (2021)
92. The Outcome of Covid-19 in Patients With a History of Taking Rituximab: A Narrative Review, Iranian Journal of Medical Sciences (2021)
93. The Possible Direct Correlation Between Cognitive Impairment and Fear of Catching Covid-19 Among Patients With Multiple Sclerosis, Iranian Journal of Psychiatry (2021)
94. The Possible Role of Interleukin-6 As a Regulator of Insulin Sensitivity in Patients With Neuromyelitis Optica Spectrum Disorder, BMC Neurology (2021)
95. The Prevalence of Cognitive Impairment in Patients With Neuromyelitis Optica Spectrum Disorders (Nmosd): A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
96. The Prevalence of Cognitive Impairment in Patients With Neuromyelitis Optica Spectrum Disorders (Nmosd): A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
97. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
98. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
99. Umbilical Cord Mesenchymal Stem Cells As Well As Their Released Exosomes Suppress Proliferation of Activated Pbmcs in Multiple Sclerosis, Scandinavian Journal of Immunology (2021)
100. Whole Grains and Legumes Consumption in Association With Neuromyelitis Optica Spectrum Disorder Odds, Current Journal of Neurology (2021)
101. Widespread Disruptions of White Matter in Familial Multiple Sclerosis: Dti and Noddi Study, Frontiers in Neurology (2021)
102. A Randomized Controlled Trial Investigating the Effects of a Mediterranean-Like Diet in Patients With Multiple Sclerosis-Associated Cognitive Impairments and Fatigue, Current Journal of Neurology (2020)
103. Aggressive Course of Cognitive Impairment in Multiple Sclerosis: A New Term for the Management of Patients, Journal of Clinical Neuroscience (2020)
104. Anti-N-Methyl-D-Aspartate Receptor Optic Neuritis in a Patient Without History of Encephalopathy, Taiwan Journal of Ophthalmology (2020)
105. Bladder Dysfunction in Iranian Patients With Multiple Sclerosis, Journal of Multidisciplinary Healthcare (2020)
106. Dietary Total Antioxidant Capacity and Neuromyelitis Optica Spectrum Disorder Susceptibility, Nutrition and Food Science (2020)
107. Effect of Pregnancy and Exclusive Breastfeeding on Multiple Sclerosis Relapse Rate and Degree of Disability Within Two Years After Delivery, Clinical Neurology and Neurosurgery (2020)
108. Efficacy and Safety of Rituximab in Patients With Refractory Neuromyelitis Optica Spectrum Disorders: A Prospective Observation in Iranian Cases, Caspian Journal of Internal Medicine (2020)
109. Encephalopathy Associated With Covid-19 in a Patient With Multiple Sclerosis, Journal of NeuroVirology (2020)
110. Environmental and Genetic Risk Factors in the Development of Neuromyelitis Optica, Expert Review of Ophthalmology (2020)
111. Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects, Neurological Sciences (2020)
112. Evaluation of Covid-19 Infection in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Report From Iran, Multiple Sclerosis and Related Disorders (2020)
113. Evaluation of Emotional Intelligence (Ei) in Neuromyelitis Optica Spectrum Disorder (Nmosd) Patients Compared to Healthy Individuals, Multiple Sclerosis and Related Disorders (2020)
114. Evaluation of the Level of Anxiety Among Iranian Multiple Sclerosis Fellowships During the Outbreak of Covid-19, Archives of Iranian Medicine (2020)
115. Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching Covid-19 and Its Effects on the Ms Symptoms, Basic and Clinical Neuroscience (2020)
116. Evaluation of the Rate of Covid-19 Infection, Hospitalization and Death Among Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
117. Evaluation of Types of Psychological Disorders in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd), Multiple Sclerosis and Related Disorders (2020)
118. History of Multiple Sclerosis in Iran, Archives of Iranian Medicine (2020)
119. Impact of Supplementation With Multivitamin-Mineral Specially Formulated to Improve Fatigue and Inflammatory State in Patients With Multiple Sclerosis: A Triple-Blind, Randomized, Placebo-Controlled Trial, Current Journal of Neurology (2020)
120. Knowledge Regarding Covid-19 Pandemic in Patients With Multiple Sclerosis (Ms): A Report From Iran, Multiple Sclerosis and Related Disorders (2020)
121. Multiple Sclerosis and Human Leukocyte Antigen Genotypes: Focus on the Middle East and North Africa Region, Multiple Sclerosis Journal - Experimental# Translational and Clinical (2020)
122. Neural Implant for the Treatment of Multiple Sclerosis, Medical Hypotheses (2020)
123. Neuropsychiatric and Cognitive Effects of the Covid-19 Outbreak on Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
124. One Aspect of Coronavirus Disease (Covid-19) Outbreak in Iran: High Anxiety Among Ms Patients, Multiple Sclerosis and Related Disorders (2020)
125. Opportunities and Threats: The Necessity of Research in Dealing With the Rapid Spread of Coronavirus Disease 2019 (Covid-19) in Iran, Archives of Clinical Infectious Diseases (2020)
126. Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients With Multiple Sclerosis, Journal of Multidisciplinary Healthcare (2020)
127. Predictors of Suicidal Ideation Among Iranian Patients With Multiple Sclerosis, Current Journal of Neurology (2020)
128. Progressive Myelopathy in a Patient With Pediatric Onset Neuromyelitis Optica Spectrum Disorder: A Case Report and a Mini Review, Acta Neurologica Taiwanica (2020)
129. Psychiatric Advice During Covid-19 Pandemic for Patients With Multiple Sclerosis, Iranian Journal of Psychiatry and Behavioral Sciences (2020)
130. Redox Imbalance in Cd4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients, Oxidative Medicine and Cellular Longevity (2020)
131. Rehabilitation Recommendations for Multiple Sclerosis Patients During the Covid-19 Pandemic, Archives of Iranian Medicine (2020)
132. Sensory-Neural Hearing Loss As an Early Rebound Relapse After Fingolimod Cessation in Multiple Sclerosis, Iranian Journal of Otorhinolaryngology (2020)
133. Stressful Life Events, Socioeconomic Status, and the Risk of Neuromyelitis Optica Spectrum Disorder: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2020)
134. The Big Challenge for Neurologists in Treating Patients With Multiple Sclerosis in the Post-Covid-19 Era, Multiple Sclerosis and Related Disorders (2020)
135. The Co-Occurrence of Multiple Sclerosis and Evans Syndrome: A Case Report, Caspian Journal of Internal Medicine (2020)
136. The Possible Beneficial Effects of Higher Vitamin B6 Intake From Diet on Cognitive Function of Patients With Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2020)
137. The Role of the Brain in the Treatment of Multiple Sclerosis As a Connectomopathy, Medical Hypotheses (2020)
138. Tumefactive Demyelinating Lesions After Initiating Fingolimod in Patient With Multiple Sclerosis: A Case Report, Revue Neurologique (2020)
139. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab, Acta Neurologica Taiwanica (2020)
140. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab, Acta neurologica Taiwanica (2020)
141. Altered Expression of Mir-326 in T Cell-Derived Exosomes of Patients With Relapsing-Remitting Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2019)
142. Autoimmune Diseases Associated With Neuromyelitis Optica Spectrum Disorders: A Literature Review, Multiple Sclerosis and Related Disorders (2019)
143. Bilateral Extensive Lesions of the Brain in a Patient With Neuromyelitis Optica Manifested With Seizure and Cognitive Impairments, Revue Neurologique (2019)
144. Burnt City and the Evolution of Cognitive Science, Archives of Iranian medicine (2019)
145. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
146. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
147. Corpus Callosum Agenesis and Clinically Isolated Syndrome (Cis): A Case Report, Multiple Sclerosis and Related Disorders (2019)
148. Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder a Case Series From Iran, Iranian Journal of Child Neurology (2019)
149. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)
150. Lack of Attention to Epidemiological Study of Neuromyelitis Optica Spectrum Disorder Compared With That of Multiple Sclerosis in Iran, International Journal of MS Care (2019)
151. Management of Seizures in Patients With Multiple Sclerosis; an Iranian Consensus, Epilepsy and Behavior (2019)
152. Management of Seizures in Patients With Multiple Sclerosis; an Iranian Consensus, Epilepsy and Behavior (2019)
153. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)
154. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)
155. Neuromyelitis Optica Spectrum Disorder With Radiological Manifestation of Multiple Sclerosis in the First Brain Mri: A Case Report, Future Neurology (2019)
156. Pediatric Multiple Sclerosis and Its Familial Recurrence: A Population Based Study (1999–2017), Multiple Sclerosis and Related Disorders (2019)
157. Progressive Solitary Sclerosis Presented With Diplopia: A Case Report, Multiple Sclerosis and Related Disorders (2019)
158. The Association Between Dietary Sugar Intake and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Multiple Sclerosis and Related Disorders (2019)
159. The Correlation Between Dyslipidemia and Cognitive Impairment in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2019)
160. The Oldest Image of a Woman During Vaginal Delivery in the Continental Shelf of Iran, Archives of Iranian medicine (2019)
161. The Relationship Between Cognitive Function and Body Mass Index in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2019)
162. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in Patients With Multiple Sclerosis: A Pilot Study With Booster Injection, Immunological Investigations (2019)
163. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab, Acta Neurologica Belgica (2019)
164. When an Octopus Has Ms: Application of Neurophysiology and Immunology of Octopuses for Multiple Sclerosis, Medical Hypotheses (2019)
165. A Comparison of Pediatric and Adult Neuromyelitis Optica Spectrum Disorders: A Review of Clinical Manifestation, Diagnosis, and Treatment, Journal of the Neurological Sciences (2018)
166. A Presentation of Ulcerative Colitis After Rituximab Therapy in a Patient With Multiple Sclerosis and Literature Review, Multiple Sclerosis and Related Disorders (2018)
167. Anti-Jc Virus Antibody Sera Positivity and Index Value Among Patients With Multiple Sclerosis May Be Correlated With Age, Sex, and Area of Residence, Journal of NeuroVirology (2018)
168. Association of Limb-Girdle Muscular Dystrophy With Multiple Sclerosis: A Case Report, Caspian Journal of Internal Medicine (2018)
169. Clinical Effectiveness and Safety of Fingolimod in Relapsing Remitting Multiple Sclerosis in Western Iran, Neurosciences (2018)
170. Combination Treatment of Docosahexaenoic Acid (Dha) and All-Trans-Retinoic Acid (Atra) Inhibit Il-17 and Rorγt Gene Expression in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis, Neurological Research (2018)
171. Comparison of Cytokine Expression in Multiple Sclerosis Patients and Healthy Volunteers, Acta Medica Iranica (2018)
172. Environmental Risk Factors in Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Acta Neurologica Belgica (2018)
173. Immunomodulatory Function of Treg-Derived Exosomes Is Impaired in Patients With Relapsing-Remitting Multiple Sclerosis, Immunologic Research (2018)
174. Increased Expression of Mir-301A in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis Is Associated With Reduced Nkrf and Pias3 Expression Levels and Disease Activity, Journal of Neuroimmunology (2018)
175. Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab, Multiple Sclerosis and Related Disorders (2018)
176. Neuromyelitis Optica and Neuromyelitis Optica Like Spectrum Disorders: Is It Not the Time to Change the Criteria?, Multiple Sclerosis and Related Disorders (2018)
177. Serum Anti-Mullerian Hormone Levels in Multiple Sclerosis – a Multicenter Case-Control Study; [Hladiny Anti-Mullerianskeho Hormonu V Seru Pri Roztrousene Skleroze – Multicentricka Pripadova Kontrolni Studie], Ceska a Slovenska Neurologie a Neurochirurgie (2018)
178. The Prevalence, Incidence and Familial Recurrence of Multiple Sclerosis in Tehran, Iran, Multiple Sclerosis and Related Disorders (2018)
179. Catastrophic Presentation of a Patient With Combined Nmosd and Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Case Report, Acta Neurologica Belgica (2017)
180. Catastrophic Presentation of a Patient With Combined Nmosd and Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Case Report, Acta Neurologica Belgica (2017)
181. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
182. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
183. Comparing Epidemiology and Baseline Characteristic of Multiple Sclerosis and Neuromyelitis Optica: A Case-Control Study, Multiple Sclerosis and Related Disorders (2017)
184. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
185. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
186. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)
187. Optic Neuritis in a Patient With Celiac Disease, Neurologia i Neurochirurgia Polska (2017)
188. Optic Neuritis With Radiological Longitudinal Spinal Cord Involvement and Seronegative Anti-Aquaporin Antibody: Evidence From a Case Study, Multiple Sclerosis and Related Disorders (2017)
189. Sleep Disorder As a Triggering Factor for Relapse in Multiple Sclerosis, European Neurology (2017)
190. The Expression of Vdr Mrna But Not Nf-Κb Surprisingly Decreased After Vitamin D Treatment in Multiple Sclerosis Patients, Neuroscience Letters (2017)
191. Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies, Neurologic Clinics (2016)
192. Channelopathy-Related Scn10a Gene Variants Predict Cerebellar Dysfunction in Multiple Sclerosis, Neurology (2016)
193. Concomitant Multiple Sclerosis and Another Autoimmune Disease: Does the Clinical Course Change?, Clinical Neurology and Neurosurgery (2016)
194. Nmosd With an Unusual Cerebral Radiologic Manifestation, Multiple Sclerosis and Related Disorders (2016)
195. Validity and Reliability of the Persian Version of the Perception De La Scle’Rose En Plaques Et De Ses Pousse’Es Questionnaire Evaluating Multiple Sclerosis-Related Quality of Life, International Journal of Preventive Medicine (2016)
196. An Unusual Radiological Presentation of Posterior Reversible Encephalopathy Syndrome, Neurologia i Neurochirurgia Polska (2015)
197. Artistic Activity From Health Through Disease, Then Death in a Patient With Frontotemporal Dementia, Neurologia i Neurochirurgia Polska (2015)
198. Compulsion in a Different Artistic Format for a Patient With Ftd, Acta Neurologica Belgica (2015)
199. Endometriosis of the Lumbosacral Plexus: Report of a Case With Foot Drop and Chronic Pelvic Pain, Acta Neurologica Belgica (2015)
200. First Visual Evidence of Leprosy in the Continental Shelf of Iran, Iranian Journal of Public Health (2015)
201. Neuromyelitis Optica With Linear Enhancement of Corpus Callosum in Brain Magnetic Resonance Imaging With Contrast: A Case Report, Journal of Medical Case Reports (2015)
202. The Burnt City and the Evolution of the Concept of “Probability” in the Human Brain, Iranian Journal of Public Health (2015)
203. Vitamin D Levels in Multiple Sclerosis Patients: Association With Tgf-Β2, Tgf-Βri, and Tgf-Βrii Expression, Life Sciences (2015)